GGrantIndex
← Leaderboards

Mark Edward Hatley

St. Jude Children'S Research Hospital

$4,899,188
Attributed
$4,899,188
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $821.2K · FY201125
$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,899,188 · 3

By mechanism

R01$4,056,788 · 2
K08$842,400 · 1

Top collaborators

No co-investigators on record.

Most similar at St. Jude Children'S Research Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Pathway Interactions

Research focus

Pathway InteractionsGenesMalignant NeoplasmsTumorLaboratoriesInsightCellsMouse ModelChildhood RhabdomyosarcomaPax7 GeneDesignChildPharmacotherapyPax3 GeneGenetically Engineered MouseGene FusionFoxo1a GeneBaseAutomobile DrivingAggressive TherapyClinical TrialsChildhoodExperimental StudyHigh Risk

Grant awards (15)

Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma$410,606
R01 · FY2025 · CA · contact PI
Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma$390,077
R01 · FY2024 · CA · contact PI
Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma$402,394
R01 · FY2023 · CA · contact PI
Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma$402,394
R01 · FY2022 · CA · contact PI
Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma$410,606
R01 · FY2021 · CA · contact PI
Defining the non-myogenic origins of pediatric rhabdomyosarcoma$410,606
R01 · FY2021 · CA · contact PI
Defining the non-myogenic origins of pediatric rhabdomyosarcoma$410,606
R01 · FY2020 · CA · contact PI
Defining the non-myogenic origins of pediatric rhabdomyosarcoma$398,287
R01 · FY2019 · CA · contact PI
Defining the non-myogenic origins of pediatric rhabdomyosarcoma$410,606
R01 · FY2018 · CA · contact PI
Defining the non-myogenic origins of pediatric rhabdomyosarcoma$410,606
R01 · FY2017 · CA · contact PI
Dissection of microRNA-21s role in non-small cell lung cancer$168,480
K08 · FY2015 · CA · contact PI
Dissection of microRNA-21s role in non-small cell lung cancer$168,480
K08 · FY2014 · CA · contact PI
Dissection of microRNA-21s role in non-small cell lung cancer$168,480
K08 · FY2013 · CA · contact PI
Dissection of microRNA-21s role in non-small cell lung cancer$168,480
K08 · FY2012 · CA · contact PI
Dissection of microRNA-21s role in non-small cell lung cancer$168,480
K08 · FY2011 · CA · contact PI